← SynDRA
Tocris-1028
SynDRA canonical compound SYN1231773 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | GRM1 |
|---|
| Mechanism of action | Glutamate receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- Glutamate receptor antagonist
- GRM1 NEGATIVE ALLOSTERIC MODULATOR
- GRM1 MODULATOR (ALLOSTERIC MODULATOR)
Cross-references
Synonyms
- PD132784
- Lopac-C-9611
- NCGC00015285-01
- NCGC00024948-01
- CPCCOEt, >
- SR-01000597466
- 7-(hydroxyimino)cyclopropa[b]chromen-1a-carboxylate ethyl ester
- AC1O3E8H
- KB-49121
- MolPort-003-940-874
- CPCCOET
- LP00300
- BRD-A05729358-001-01-2
- AKOS024456339
- L000202
- SR-01000597466-1
- SCHEMBL29384028
- NCGC00024948-02
- CPCCOEt
- CHEMBL327783
- SCHEMBL12648369
- AS-16761
- ethyl (7E)-7-hydroxyimino-1,7a-dihydrocyclopropa[b]chromene-1a-carboxylate
- HMS3267O17
- G78352
- DB-014739
- 7-hydroxyimino-1,7a-dihydrocyclopropa[b][1]benzopyran-1a-carboxylic acid ethyl ester
- HMS3412A05
- HY-101356
- orb1704593
- CPCCOEt, >=98% (HPLC)
- AC-33596
- HB0216
- MFCD00947859
- BRD-A05729358-001-02-0
- CS-0021209
- RefChem:128345
- HMS3676A05
- NCGC00024948-06
Look up Tocris-1028 in the interactive SynDRA portal →